Agilent Technologies

A
146,61
-0,76 (-0,52%)
Ultimo aggiornamento: 19:52:40
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/3/202413:00BWAgilent Presents 2024 Darlene Solomon Award to University of..
08/3/202419:08EDGAR2Form 144 - Report of proposed sale of securities
08/3/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:04EDGAR2Form 144 - Report of proposed sale of securities
07/3/202421:41EDGAR2Form 144 - Report of proposed sale of securities
05/3/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202402:05EDGAR2Form 144 - Report of proposed sale of securities
01/3/202420:13EDGAR2Form 144 - Report of proposed sale of securities
29/2/202414:00BWAgilent Presents Solutions Innovation Research Awards to..
27/2/202422:06EDGAR2Form 8-K - Current report
27/2/202422:05BWAgilent Reports First-Quarter Fiscal Year 2024 Financial..
21/2/202422:20BWAgilent Announces Cash Dividend of 23.6 Cents per Share
21/2/202422:15EDGAR2Form 8-K - Current report
21/2/202422:12BWAgilent CEO Mike McMullen to Retire; Agilent CrossLab Group..
13/2/202416:11BWAgilent Ranked Among Top 50 Most Just Companies in America
08/2/202414:00BWAgilent Wins Two Scientists’ Choice Awards for Drug..
07/2/202417:20BWAgilent to Participate in TD Cowen Health Care Conference
02/2/202414:10EDGAR2Form DEF 14A - Other definitive proxy statements
02/2/202414:00EDGAR2Form ARS - Annual Report to Security Holders
30/1/202414:00BWAgilent Announces Collaboration with Incyte to Develop..
25/1/202418:29BWAgilent to Announce First-Quarter Fiscal Year 2024 Financial..
16/1/202414:00BWAgilent Announces New ProteoAnalyzer System
05/1/202422:05EDGAR2Form 8-K - Current report
05/1/202416:29BWAgilent Named to Dow Jones Sustainability Indices for Ninth..
28/12/202319:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202316:46EDGAR2Form 144 - Report of proposed sale of securities
20/12/202315:11EDGAR2Form 8-K - Current report
20/12/202314:58BWAgilent Makes Strategic Updates to Organizational Structure
19/12/202320:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:59EDGAR2Form 144 - Report of proposed sale of securities
18/12/202316:01BWAgilent to Present at the 42nd Annual J.P. Morgan Healthcare..
15/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202320:14EDGAR2Form 144 - Report of proposed sale of securities
14/12/202321:17BWAgilent Again Named “Global Lighthouse” by World Economic..
13/12/202317:12EDGAR2Form 144 - Report of proposed sale of securities
08/12/202320:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202317:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202317:41EDGAR2Form 144 - Report of proposed sale of securities
07/12/202314:00BWAgilent Resolve Raman Receives Multiple Recognitions for..
04/12/202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00BWAgilent BioTek Cytation C10 Confocal Imaging Reader Enhanced..
27/11/202319:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202319:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202319:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 147,54 Min: 145,95 Max: 147,68
Chiusura: 147,37

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network